Skip to main content

and
  1. No Access

    Article

    How to manage coagulopathies in critically ill patients

    Coagulopathy is a severe and frequent complication in critically ill patients, for which the pathogenesis and presentation may be variable depending on the underlying disease. Based on the dominant clinical ph...

    Julie Helms, Toshiaki Iba, Jean Marie Connors, Satoshi Gando in Intensive Care Medicine (2023)

  2. Article

    What do sepsis-induced coagulation test result abnormalities mean to intensivists?

    Marcel Levi, Marcus J. Schultz in Intensive Care Medicine (2017)

  3. No Access

    Article

    What’s new in the diagnostic criteria of disseminated intravascular coagulation?

    Satoshi Gando, Ferhat Meziani, Marcel Levi in Intensive Care Medicine (2016)

  4. No Access

    Article

    Endothelial injury in sepsis

    Marcel Levi, Tom van der Poll in Intensive Care Medicine (2013)

  5. Article

    Open Access

    Early intravenous unfractionated heparin and outcome in acute lung injury and acute respiratory distress syndrome – a retrospective propensity matched cohort study

    Acute lung injury (ALI) is characterized by a pro-coagulant state. Heparin is an anticoagulant with anti-inflammatory properties. Unfractionated heparin has been found to be protective in experimental models o...

    Jorrit J Hofstra, Alexander P J Vlaar, David J Prins, Gavin Koh in BMC Pulmonary Medicine (2012)

  6. Article

    Open Access

    2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema

    We published the Canadian 2003 International Consensus Algorithm for the Diagnosis, Therapy, and Management of Hereditary Angioedema (HAE; C1 inhibitor [C1-INH] deficiency) and updated this as Hereditary angio...

    Tom Bowen, Marco Cicardi, Henriette Farkas in Allergy, Asthma & Clinical Immunology (2010)

  7. Article

    Comprehensive safety analysis of concomitant drotrecogin alfa (activated) and prophylactic heparin use in patients with severe sepsis

    Mitchell Levy, Marcel Levi, Mark D. Williams, Massimo Antonelli in Intensive Care Medicine (2009)

  8. Article

    Comprehensive safety analysis of concomitant drotrecogin alfa (activated) and prophylactic heparin use in patients with severe sepsis

    The safety of using heparin concomitantly with drotrecogin alfa (activated) {DrotAA} was explored in the XPRESS study. No heparin effect on mortality was observed. Safety results from that study are explored i...

    Mitchell Levy, Marcel Levi, Mark D. Williams, Massimo Antonelli in Intensive Care Medicine (2009)

  9. No Access

    Article

    Prescription of rh-APC differs substantially among western European countries

    Marcus J. Schultz, Marcel Levi in Intensive Care Medicine (2006)

  10. No Access

    Article

    Treatment with recombinant human activated protein C obviates additional anticoagulation during continuous venovenous hemofiltration in patients with severe sepsis

    Anne Cornélie J. M. de Pont, Catherine S. C. Bouman in Intensive Care Medicine (2003)